PAX5 and laryngotracheoesophageal cleft: The frequencies of autoantibodies to PAX5, PTCH1, and GNA11 in the LC group are 32.1%, 35.7%, and 25.0%, which are significantly higher than their frequencies in the CH and NC groups (Figure 2B,C).